Cardium Therapeutics regains listing compliance with NYSE Amex
Cardium Therapeutics reported that it had received notice from NYSE Regulation that the company is now considered to have regained compliance with the listing requirements of the NYSE Amex LLC. :theflyonthewall.com
News For CXM From The Last 14 Days
Check below for free stories on CXM the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
Subscribe for More Information